Rajat Biswas

132% H2 FY2025 | USD 1.8M | Maharashtra & Goa. Built market development & commercial excellence infrastructure: TAM/SAM/SOM analysis for regional leadership; SFDC SFE dashboards; DBS daily-management. Designed KOL programme and reference centre strategy across Maharashtra's neurosurgery network. VOC to product improvement inputs, battlecards, and BU positioning. AMC bundling construct (lifecycle management) under evaluation. Owned NPI rollout; clinical workshop delivery; daily Service coordination.

148% YTD FY2024 | 48% above AOP | USD 1.3M portfolio. Designed segment-specific GTM strategies across 4 therapeutic areas. VOC and competitive analysis translated to product improvement inputs driving formulary inclusion and multi-year lifecycle standardisation. Built CRM-based market intelligence and account-prioritisation framework. Structured tender strategy and techno-commercial agreements protecting ASP. Designed scalable channel-partner growth model. Coached and developed junior commercial team.

Neurosurgery Systems · Spine Solutions · IONM | Large Institutional Accounts. Owned product commercialization strategy — spinal implants, instrumentation, neuro drill, IONM — developing accounts from zero to repeat-revenue business. Drove IONM clinical adoption: engaged neurosurgeons and OR teams on intraoperative workflow integration and clinical safety value positioning. Built competitive intelligence framework and CRM-based pipeline forecasting infrastructure.

111% AOP | USD 1.1M portfolio | Chennai. Achieved 111% AOP through account-level adoption-gap analysis — mapping consumption patterns to identify clinical gaps and design targeted GTM strategies. Maintained commercial margins through pricing and volume strategy with procurement leadership. Structured multi-product commercial agreements driving new-account acquisition and long-term retention. Designed distributor channel governance framework improving execution and payment-cycle discipline.

29% above AOP | Zero-base entry | Bangalore & Delhi. Owned end-to-end market development and clinical adoption for neurosurgical navigation from zero to 29% above AOP. Served as cross-functional commercial-to-R&D interface: structured VOC with surgeons translated to engineering inputs for robotic navigation product development, aligning with clinical feasibility and market impact. Built KOL advocacy network, reference centres, & competitive intelligence framework. Managed and developed clinical specialist

Delivered client-facing enterprise solution deployments and operational consulting. Built foundational skills in stakeholder management, problem diagnosis, and cross-functional workflow optimisation prior to transitioning into medical devices.